Chronic Lung Disease of Prematurity Completed Phase 2 / 3 Trials for Palivizumab (DB00110)

Also known as: Bronchopulmonary Dysplasia / Dysplasia, Bronchopulmonary / Ventilator lung in newborn / Congenital pulmonary fibrosis

IndicationStatusPhase
DBCOND0044076 (Chronic Lung Disease of Prematurity)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01006629Palivizumab for Prevention of Severe Respiratory Syncytial Virus Infection in Russian ChildrenPrevention